Latest Articles & Resources FEATURED Shilpa Medicare Launches Dedicated Complex Small-Molecule CDMO Read More » Shilpa Medicare Launches Dedicated Complex Small-Molecule CDMO Read More » LATEST NEWS + INTERVIEWS CordenPharma Commits $93.1 Million to Expand Injectable Manufacturing in Italy Lonza Plans Commercial Spray-Drying Facility in Oregon Cellipont Bioservices and Xiogenix Assess Automated Cell Therapy Fill-Finish EpilepsyGTx Partners With Viralgen to Manufacture EPY201 Gene Therapy Ensera Forms Strategic Alliance With American Injectables eXoZymes Partners With Curia for NCT Technology Transfer and Scale-Up IOL Chemicals Invests $36.8 Million in Ibuprofen Capacity Expansion VVMF Receives TGA Manufacturing Licence for Sydney Viral Vector Facility Matica Biotechnology Announces Bioprocessing Collaboration With Bondwell Technologies Transcenta Therapeutics Signs Technology Licensing Deal With WuXi Biologics McKesson Acquires Global CRO Precision Medicine Group for $2.25B to Deepen Oncology Clinical Research Capabilities Alpha Genesis Launches AGI Ventures With $50M Commitment to Co-Invest in Biotech Programs Through Its Preclinical CRO Platform China’s Biotech Boom Demands a New Pharma Strategy AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Just-Evotec Biologics Initiates Phase 1 Trial of $123.9M Orthopoxvirus Antibody Program How ExoZymes Is Running a 10-CDMO RFP for CDMO Selection Rose BioSolutions Appoints David Enloe as CEO Scinai Immunotherapeutics Ends PC111 License Deal, Refocuses on NanoAb Platform Gilead Sciences Opens 182,000-Square-Foot Research Center in California Charles River Laboratories Expands Endotoxin Cartridge Capacity With Automated Suite HOVIONE Names Stefan Doboczky as CEO PODCAST INTERVIEWS How ExoZymes Is Running a 10-CDMO RFP for CDMO Selection How EU Sustainability Regulations Are Reshaping CDMO Manufacturing “Stop Talking About Resilience in the Future Tense”: What Pharma Actually Wants From CDMOs
McKesson Acquires Global CRO Precision Medicine Group for $2.25B to Deepen Oncology Clinical Research Capabilities
Alpha Genesis Launches AGI Ventures With $50M Commitment to Co-Invest in Biotech Programs Through Its Preclinical CRO Platform
